ACS Medicinal Chemistry Letters · 2019 · 14 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntiparasitic AgentsAntiparasitic PharmacologyCovalent Drug DesignCovalent Inhibitor DesignDrug-metabolizing EnzymesEnzyme InhibitionAntimalarial AgentsAntimalarial Drug DevelopmentCovalent Enzyme InhibitorsCovalent InhibitorsMalaria ResistancePlasmodium FalciparumSelectivityTarget Enzyme Inhibition
Covalent inhibitors of PfGAPDH characterized by a 3-bromoisoxazoline warhead were developed, and their mode of interaction with the target enzyme was interpreted by means of molecular modeling studies: some of them displayed a submicromolar antiplasmodial activity against both chloroquine sensitive and resistant strains of Plasmodium falciparum, with good selectivity indices.
21